Ancora Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-16,160
Closed -$589K 1519
2020
Q3
$589K Sell
16,160
-15,090
-48% -$561K 0.02% 405
2020
Q2
$1.17M Buy
31,250
+3,410
+12% +$136K 0.05% 290
2020
Q1
$1.02M Buy
27,840
+8,380
+43% +$325K 0.05% 313
2019
Q4
$788K Hold
19,460
0.03% 413
2019
Q3
$675K Buy
19,460
+4,040
+26% +$133K 0.03% 400
2019
Q2
$489K Buy
15,420
+1,930
+14% +$57.4K 0.02% 425
2019
Q1
$403K Sell
13,490
-4,036
-23% -$116K 0.02% 461
2018
Q4
$542K Buy
17,526
+6,175
+54% +$225K 0.03% 399
2018
Q3
$430K Sell
11,351
-3,510
-24% -$133K 0.02% 516
2018
Q2
$570K Buy
+14,861
New +$501K 0.02% 451
2017
Q1
Sell
-390
Closed -$20K 955
2016
Q4
$20K Buy
+390
New +$18.8K ﹤0.01% 934

Other funds holding PBH

Ancora Advisors's PBH Position: Q4 2020 in Review

Ancora Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2020, closing a stake of 16,160 shares — an estimated $589K sold.

Ancora Advisors first reported a position in PBH in Q4 2016 and held it in 11 quarters. The position peaked at $1.17M in Q2 2020. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Ancora Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2020 after selling out during the quarter.
  • Ancora Advisors sold 16,160 Prestige Consumer Healthcare shares in Q4 2020, an estimated $589K.
  • Ancora Advisors first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 11 quarters.
  • Ancora Advisors's Prestige Consumer Healthcare position peaked at $1.17M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Ancora Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.